SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry. |
As Of Filer Filing For·On·As Docs:Size 11/06/20 Obalon Therapeutics Inc. 10-Q 9/30/20 60:5.2M |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 388K 2: EX-10.1 Material Contract HTML 354K 3: EX-31.1 Certification -- §302 - SOA'02 HTML 23K 4: EX-31.2 Certification -- §302 - SOA'02 HTML 24K 5: EX-32.1 Certification -- §906 - SOA'02 HTML 21K 12: R1 Document and Entity Information HTML 48K 13: R2 Condensed Consolidated Balance Sheets HTML 97K 14: R3 Condensed Consolidated Balance Sheets HTML 26K (Parenthetical) 15: R4 Condensed Consolidated Statements of Operations HTML 66K and Comprehensive Loss 16: R5 Condensed Consolidated Statements of Stockholders' HTML 107K Equity 17: R6 Condensed Consolidated Statements of Cash Flows HTML 109K 18: R7 Organization and Basis of Presentation HTML 30K 19: R8 Summary of Significant Accounting Policies HTML 39K 20: R9 Fair Value Measurements HTML 83K 21: R10 Net Loss per Share HTML 45K 22: R11 Balance Sheet Details HTML 69K 23: R12 Loan HTML 24K 24: R13 Stock-Based Compensation HTML 89K 25: R14 Stockholders' Equity HTML 37K 26: R15 Income Taxes HTML 22K 27: R16 Commitments and Contingencies HTML 45K 28: R17 Variable Interest Entity HTML 22K 29: R18 Summary of Significant Accounting Policies HTML 59K (Policies) 30: R19 Fair Value Measurements (Tables) HTML 83K 31: R20 Net Loss per Share (Tables) HTML 47K 32: R21 Balance Sheet Details (Tables) HTML 72K 33: R22 Stock-Based Compensation (Tables) HTML 93K 34: R23 Stockholders' Equity (Tables) HTML 23K 35: R24 Commitments and Contingencies (Tables) HTML 32K 36: R25 Organization and Basis of Presentation - HTML 38K Additional Information (Detail) 37: R26 Summary of Significant Accounting Policies - HTML 23K Narrative (Details) 38: R27 Fair Value Measurements - Schedule of Assets and HTML 49K Liabilities Measured at Fair Value on Recurring Basis (Details) 39: R28 Fair Value Measurements - Schedule of Fair Value HTML 32K Assumptions (Details) 40: R29 Fair Value Measurements - Schedule of Liabilities HTML 26K Measured at Fair Value (Details) 41: R30 Net Loss per Share - Schedule of Computation of HTML 32K Basic and Diluted Net Loss Per Share of Common Stock (Details) 42: R31 Net Loss per Share - Schedule of Anti-Dilutive HTML 24K Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) 43: R32 Balance Sheet Details - Schedule of Inventory HTML 27K (Details) 44: R33 Balance Sheet Details - Narrative (Details) HTML 28K 45: R34 Balance Sheet Details - Schedule of Other Current HTML 28K Assets (Details) 46: R35 Balance Sheet Details - Schedule of Property and HTML 45K Equipment, Net (Details) 47: R36 Balance Sheet Details - Schedule of Other Current HTML 35K Liabilities (Details) 48: R37 Loan - Additional Information (Details) HTML 24K 49: R38 Stock-Based Compensation - Additional Information HTML 36K (Details) 50: R39 Stock-Based Compensation - Summary of Stock-Based HTML 28K Compensation (Details) 51: R40 Stock-Based Compensation - Summary of Stock Option HTML 70K Transactions (Details) 52: R41 Stock-Based Compensation - Summary of Restricted HTML 58K Stock Awards (Details) 53: R42 Stockholders' Equity - Additional Information HTML 70K (Details) 54: R43 Stockholders' Equity - Schedule of Common Stock HTML 28K Reserved for Future Issuance (Details) 55: R44 Commitments and Contingencies - Additional HTML 51K Information (Details) 56: R45 Commitments and Contingencies - Schedule of Future HTML 50K Noncancelable Minimum Payment Obligations Under Operating Lease (Details) 57: R46 Variable Interest Entity (Details) HTML 23K 59: XML IDEA XML File -- Filing Summary XML 103K 58: EXCEL IDEA Workbook of Financial Reports XLSX 71K 6: EX-101.INS XBRL Instance -- obln-20200930 XML 1.22M 8: EX-101.CAL XBRL Calculations -- obln-20200930_cal XML 174K 9: EX-101.DEF XBRL Definitions -- obln-20200930_def XML 327K 10: EX-101.LAB XBRL Labels -- obln-20200930_lab XML 1.15M 11: EX-101.PRE XBRL Presentations -- obln-20200930_pre XML 647K 7: EX-101.SCH XBRL Schema -- obln-20200930 XSD 112K 60: ZIP XBRL Zipped Folder -- 0001427570-20-000062-xbrl Zip 149K
|
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 11/6/20 | 8-K | ||
For Period end: | 9/30/20 | |||
12/31/19 | 10-K, 10-K/A | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/09/21 ReShape Lifesciences Inc. S-4/A 89:13M Toppan Merrill/FA 3/30/21 ReShape Lifesciences Inc. S-4 25:18M Toppan Merrill/FA 3/12/21 ReShape Lifesciences Inc. 10-K 12/31/20 83:8.4M Toppan Merrill Bridge/FA 2/03/21 ReShape Lifesciences Inc. S-8 2/03/21 3:211K Toppan Merrill Bridge/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/14/20 ReShape Lifesciences Inc. 8-K:1,3,9 8/14/20 3:203K 7/24/19 ReShape Lifesciences Inc. 8-K:3,5,8,9 7/23/19 3:71K 6/14/18 ReShape Lifesciences Inc. 8-K:5,9 6/14/18 2:53K 9/26/16 ReShape Lifesciences Inc. S-1/A 17:4M Donnelley … Solutions/FA |